High prevalence of diabetes and intermediate hyperglycemia - the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Schmidt, Maria Inês ^a   Hoffmann, Juliana F ^a   Diniz, Maria De Fátima Sander ^b   Lotufo, Paulo A ^c   Griep, Rosane Härter ^d   Bensenor, Isabela M ^c   Mill, José G ^e   Barreto, Sandhi Maria ^b   L Aquino, Estela M ^f   Duncan, Bruce B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^f FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Brazil; Diabetes mellitus; Hyperglycemia; Prediabetic state; Prevalence

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAZILIAN; COHORT ANALYSIS; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INTERMEDIATE HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE;

EID: 84928713286     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-123     Document Type: Article

References (28)

1. World Health Organization: Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. Geneva: WHO; 2013.
2. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez M-G, Baxter A, Bell ML, Benjamin EJ, Bennett D, et al: Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2163-2196.
3. International Diabetes Federation: IDF Diabetes Atlas. 6th edition. Brussels: IDF; 2013.
4. Malerbi DA, Franco LJ: Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. Diabetes Care 1992, 15:1509-1516.
5. Schmidt MI, Duncan BB, Azevedo e Silva G, Menezes AM, Monteiro CA, Barreto SM, Chor D, Menezes PR: Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet 2011, 377:1949-1961.
6. Morris DH, Khunti K, Achana F, Srinivasan B, Gray LJ, Davies MJ, Webb D: Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: A meta-Analysis. Diabetologia 2013, 56:1489-1493.
7. Aquino EML, Barreto SM, Bensenor IM, Carvalho MS, Chor D, Duncan BB, Lotufo PA, Mill JG, Molina MDC, Mota ELA, Passos VMA, Schmidt MI, Szklo M: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. Am J Epidemiol 2012, 175:315-324.
8. Schmidt MI, Duncan BB, Mill JG, Lotufo PA, Chor D, Barreto SM, Aquino EM, Passos VMA, Matos SM, M d CB M, Carvalho MS, Bensenor IM: Cohort profile: Longitudinal Study of Adult Health (ELSA-Brasil). Int J Epidemiol 2014 doi: 10.1093/ije/dyu027.
9. Fedeli LG, Vidigal PG, Leite CM, Castilhos CD, Pimentel RA, Maniero VC, Mill JG, Lotufo PA, Pereira AC, Bensenor IM: Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil. Rev Saude Publica 2013, 47(Suppl 2):63-71.
10. World Health Organization: Definition, Diagnosis and Classification Of Diabetes Mellitus and its Complications. Report of a WHO Consultation. 1999.
11. American Diabetes Association: Standards of medical care in diabetes: 2014. Diabetes Care 2014, 37(Suppl 1):S14-S80.
12. World Health Organization: Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva: WHO; 2011.
13. World Health Organization: Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consulation. Geneva: WHO; 2006.
14. Gillett MJ: International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327-1334. Clin Biochem Rev Aust Assoc Clin Biochem 2009, 30:197-200.
15. Schmidt MI, Duncan BB, Hoffmann JF, de Moura L, Malta DC, de Carvalho RMSV: Prevalence of diabetes and hypertension based on self-reported morbidity survey, Brazil, 2006. Rev Saude Publica 2009, 43(Suppl 2):74-82.
16. Brasil. Ministério da Saúde: Vigitel Brasil 2013: Vigilância de Fatores de Risco E Proteção Para Doenças Crônicas Por Inquérito Telefônico. Brasília: MS; 2014.
17. Maruthur NM, Kao WHL, Clark JM, Brancati FL, Cheng C-Y, Pankow JS, Selvin E: Does genetic ancestry explain higher values of glycated hemoglobin in African Americans? Diabetes 2011, 60:2434-2438.
18. Bullard KM, Saydah SH, Imperatore G, Cowie CC, Gregg EW, Geiss LS, Cheng YJ, Rolka DB, Williams DE, Caspersen CJ: Secular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010. Diabetes Care 2013, 36:2286-2293.
19. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China National Diabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101.
20. Mc Donald PAJ, Montenegro GJA, Cruz GCE, Moreno de Rivera AL, Cumbrera OA: Prevalence, sociodemographic distribution, treatment and control of diabetes mellitus in Panama. Diabetol Metab Syndr 2013, 5:69.
21. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen C-S, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G, China Noncommunicable Disease Surveillance Group: Prevalence and control of diabetes in Chinese adults. JAMA 2010, 2013(310):948-959.
22. Borch-Johnsen K, Colagiuri S, Balkau B, Glömer C, Carstensen B, Ramachandran A, Dong Y, Gao W: Creating a pandemic of prediabetes: The proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 2004, 47:1396-1402.
23. Monteiro CA, Conde WL, Popkin BM: Income-specific trends in obesity in Brazil: 1975-2003. Am J Public Health 2007, 97:1808-1812.
24. Ferreira SR, Iunes M, Franco LJ, Iochida LC, Hirai A, Vivolo MA: Disturbances of glucose and lipid metabolism in first and second generation Japanese-Brazilians. Japanese-Brazilian Diabetes Study Group. Diabetes Res Clin Pract 1996, 34(Suppl):S59-S63.
25. Selvin E, Crainiceanu CM, Brancati FL, Coresh J: Short-Term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007, 167:1545-1551.
26. Instituto Brasileiro de Geografia e Estatística: Atlas Do Censo Demográfico 2010. Rio de Janeiro: Ministério do Planejamento, Orçamento e Gestão, Instituto Brasileiro de Geografia e Estatística; 2013.
27. Emerging Risk Factors Collaboration, Seshasai SRK, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njølstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J: Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011, 364:829-841.
28. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE: Diabetes: A 21st century challenge. Lancet Diabetes Endocrinol 2014, 2:56-64